PETER AKOS MIGALY
Medical Practice in Indiana
License number
Pennsylvania MD058211L
Category
Medicine
Type
Medical Physician and Surgeon
Address
Address
2
Indiana
Blairsville, PA 15717
Blairsville, PA 15717
Personal information
See more information about PETER AKOS MIGALY at radaris.comName
Address
Phone
4630 Windbrook Dr, Murrysville, PA 15668
400 45Th St, Pittsburgh, PA 15201
417 Glen Malcolm Dr #C, Glenshaw, PA 15116
4630 Windbrook Dr, Murrysville, PA 15668
417C Glen Malcolm Dr, Glenshaw, PA 15116
Professional information
Combination Therapy For Cognitive Distortions, Resisting Relapse Of Unipolar Non-Psychotic Depression
US Patent:
2012028, Nov 15, 2012
Filed:
May 25, 2011
Appl. No.:
13/068946
Inventors:
Peter Migaly - Blairsville PA, US
International Classification:
A61K 31/496, A61P 25/24, A61K 31/519
US Classification:
51425307, 51425941
Abstract:
The present invention relates to a new method of treatment for persons meeting diagnoses for major depressive disorder, or other unipolar (non-bipolar, non-psychotic and non-treatment resistant) depression. The method comprises administering a combination of two categories of drugs, antipsychotics or dopamine system stabilizers, in combination with a newer antidepressant such as a selective serotonin reuptake inhibitor, as initial treatment or as soon as possible. The method targets the prevention of suicide, and provides other benefits including preventing disease progression development of tolerance toward the antidepressants. Another aspect of the invention relates to using the method for alleviating cognitive distortion and related functional impairment or health risks, and/or using the method for smoking cessation or nicotine withdrawal.
Method Of Diagnosing, Treating And Educating Individuals With And/Or About Depression
US Patent:
2006015, Jul 13, 2006
Filed:
Jan 12, 2005
Appl. No.:
11/034447
Inventors:
Peter Migaly - Blairsville PA, US
International Classification:
A61B 19/00
US Classification:
128898000
Abstract:
The present invention relates to methods of correcting misconceptions in the DSM, which can affect improved diagnosis and testing for depression, resulting in better patient satisfaction and global improvement. Also provided are methods comprising administering various medications to produce a “pseudo-placebo” effect in depression, which can guide in selecting a particular treatment method for a more effective antidepressant effect. Another aspect of the invention relates to clinical neuroplasticity in depression by providing a method that increases patient compliance with medication, decreases the bias or prejudice in the public against depression/mental illness, decreases the percentage of treatment resistant depression, decreases patients' resistance and inappropriate use of less effective treatment or treatment without medication because of the existing misperception. Similar methods also can be used successfully for other conditions where depressive symptoms are often present as coexisting condition, such as nicotine addiction, smoking cessation, overweight/weight control and pain management.
Combination Therapy For Depression, Prevention Of Suicide, And Various Medical And Psychiatric Conditions
US Patent:
2004020, Oct 14, 2004
Filed:
Jul 25, 2003
Appl. No.:
10/627358
Inventors:
Peter Migaly - Blairsville PA, US
International Classification:
A61K031/551, A61K031/519
US Classification:
514/220000, 514/259410
Abstract:
The present invention relates to a new method of treatment for persons meeting diagnoses for major depressive disorder, or other unipolar (non-bipolar, non-psychotic and non-treatment resistant) depression. The method comprises administering a combination of two categories of drugs, antipsychotics or dopamine system stabilizers, in combination with a newer antidepressant such as a selective serotonin reuptake inhibitor, as initial treatment or as soon as possible. The method targets the prevention of suicide, and provides other benefits including preventing disease progression development of tolerance toward the antidepressants. Another aspect of the invention relates to using the method for alleviating cognitive distortion and related functional impairment or health risks, and/or using the method for smoking cessation or nicotine withdrawal.